Condensed Consolidated Statements of Shareholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Accumulated Deficit
Balance (in shares) at Jun. 30, 2021		71,258,047
Balance at Jun. 30, 2021	$ 151,393	$ 462,775	$ (311,382)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock based compensation and exercises (net) (in shares)		20,958
Stock-based compensation and exercises (net)	1,762	$ 1,762
Retirement of common stock (in shares)		(319,823)
Net income (loss)	(1,291)		(1,291)
Balance (in shares) at Sep. 30, 2021		70,959,182
Balance at Sep. 30, 2021	151,864	$ 464,537	(312,673)
Balance (in shares) at Jun. 30, 2021		71,258,047
Balance at Jun. 30, 2021	151,393	$ 462,775	(311,382)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued for acquisition	0
Net income (loss)	377
Balance (in shares) at Mar. 31, 2022		71,097,674
Balance at Mar. 31, 2022	157,243	$ 468,248	(311,005)
Balance (in shares) at Sep. 30, 2021		70,959,182
Balance at Sep. 30, 2021	151,864	$ 464,537	(312,673)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock based compensation and exercises (net) (in shares)		28,316
Stock-based compensation and exercises (net)	1,453	$ 1,453
Net income (loss)	(468)		(468)
Balance (in shares) at Dec. 31, 2021		70,987,498
Balance at Dec. 31, 2021	152,849	$ 465,990	(313,141)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock based compensation and exercises (net) (in shares)		110,176
Stock-based compensation and exercises (net)	2,258	$ 2,258
Net income (loss)	2,136		2,136
Balance (in shares) at Mar. 31, 2022		71,097,674
Balance at Mar. 31, 2022	157,243	$ 468,248	(311,005)
Balance (in shares) at Jun. 30, 2022		71,188,053
Balance at Jun. 30, 2022	156,833	$ 469,918	(313,085)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock based compensation and exercises (net) (in shares)		30,077
Stock-based compensation and exercises (net)	1,318	$ 1,318
Repurchase of Series A convertible preferred stock	(1,733)	$ (1,733)
Net income (loss)	(8,574)		(8,574)
Balance (in shares) at Sep. 30, 2022		71,218,130
Balance at Sep. 30, 2022	147,844	$ 469,503	(321,659)
Balance (in shares) at Jun. 30, 2022		71,188,053
Balance at Jun. 30, 2022	156,833	$ 469,918	(313,085)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued for acquisition	3,942
Net income (loss)	(2,199)
Balance (in shares) at Mar. 31, 2023		72,509,261
Balance at Mar. 31, 2023	159,731	$ 475,015	(315,284)
Balance (in shares) at Sep. 30, 2022		71,218,130
Balance at Sep. 30, 2022	147,844	$ 469,503	(321,659)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock based compensation and exercises (net) (in shares)		3,919
Stock-based compensation and exercises (net)	160	$ 160
Common stock issued for acquisition (in shares)		1,240,920
Common stock issued for acquisition	3,942	$ 3,942
Net income (loss)	(573)		(573)
Balance (in shares) at Dec. 31, 2022		72,462,969
Balance at Dec. 31, 2022	151,373	$ 473,605	(322,232)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock based compensation and exercises (net) (in shares)		46,292
Stock-based compensation and exercises (net)	1,410	$ 1,410
Net income (loss)	6,948		6,948
Balance (in shares) at Mar. 31, 2023		72,509,261
Balance at Mar. 31, 2023	$ 159,731	$ 475,015	$ (315,284)